Results

Total Results: 1,524 records

Showing results for "drugs".

1461. Weight-Gain-Prevention Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
      January 01, 2020 - 1 Comparative Effectiveness Review Number 97 Strategies To Prevent Weight Gain Among Adults Executive Summary Background Condition One of the Healthy People 2020 national objectives is to increase the prevalence of a healthy weight among adults to 34 percent and to reduce the prevalence of obesity amon…

1462. Stroke-Atrial-Fibrillation Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
      August 01, 2013 - , Bleeding history or predisposition, Labile international normalized ratio, Elderly [>65 years], Drugs … Despite all the potential advantages of the new drugs demonstrated in the clinical trials when compared … with warfarin, the new drugs still do not have a well-validated and -studied immediate antidote. … The shorter half-life of the novel drugs may help in the management of bleeding episodes in patients … receiving these drugs and should provide comfort that bleeding can be controlled without an antidote

1463. Disposition of Comments for CER 165 Fecal Incontinence (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
      March 21, 2016 - For example, the easiest treatments to study (drugs) are not necessarily those that are used most … With diet drugs being 'symptom' and replacing sphincter being 'cure' - the issue would be what does … Stool modifying drugs are listed as BOTH pharmacological treatments and standard care treatments. … We assume that the Reviewer is referring to diet, over the counter drugs, PFMT, education, toileting … offers any advantage over standard care (such as dietary fiber supplementation, stool- modifying drugs

1464. Stakeholder Involvement in Improving Comparative Effectiveness Reviews: AHRQ and the Effective Health Care Program (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
      September 01, 2011 - support research with a focus on outcomes, comparative clinical effectiveness, and appropriateness of pharmaceuticals … “Treating Type 2 Diabetes, The Oral Diabetes Drugs, comparing Effectiveness, Safety, and Price.” … Consumer Reports Best Buy Drugs. Yonkers, NY: Consumers Union; 2006. 8.

1465. Hypertension-Pulmonary-Arterial Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
      April 01, 2013 - These new data may clarify any effect on mortality and gauge the comparative effectiveness of these drugs … Additionally, combination drug therapy (using multiple drugs with different mechanisms of action) is … In order to 5 optimize PAH care, newer information regarding the latest drugs and combination therapies … compared a single drug (monotherapy) with placebo or standard therapy and included the following drugs … Drugs did not significantly differ in their odds of causing dizziness or diarrhea.

1466. Respiratory Failure | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/respiratory-failure

1467. Fatty Liver Disease | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/fatty-liver-disease

1468. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
      May 22, 2012 - Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation … Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. … nebivolol, timolol) • Calcium channel blockers (verapamil, diltiazem) Clarification that these drugs … nebivolol, timolol) • Calcium channel blockers (verapamil, diltiazem) Clarification that these listed drugs … cardioversion and patient- enabled cardioversion using an ICD • Studies investigating use of antiarrhythmic drugs

1469. Machine Learning Tools To (Semi-)Automate Evidence Synthesis: A Rapid Review and Evidence Map, Version 2 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/white-paper-machine-learning-tools-v2.pdf
      July 01, 2025 - Machine Learning Tools To (Semi-)Automate Evidence Synthesis: A Rapid Review and Evidence Map, Version 2 White Paper Machine Learning Tools To (Semi-)Automate Evidence Synthesis: A Rapid Review and Evidence Map, Version 2 Prepared for: Agency for Healthcare Research and Quality U.S. Department of H…

1470. Research White Paper_Machine Learning Tools To (Semi-)Automate Evidence Synthesis: A Rapid Review and Evidence Map, 2025 Review Update (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/machine-learning-tools-white-paper-2025-update.pdf
      January 01, 2025 - Research White Paper_Machine Learning Tools To (Semi-)Automate Evidence Synthesis: A Rapid Review and Evidence Map, 2025 Review Update Research White Paper Machine Learning Tools To (Semi-)Automate Evidence Synthesis: A Rapid Review and Evidence Map, 2025 Review Update Research White Paper Machine Lear…

1471. uterine-fibroids-protocol-160301 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
      March 01, 2016 -  bleeding;;  In  vitro   fertilization;;  Precocious  puberty;;  Prostate  cancer   AstraZeneca   Pharmaceuticals … indications:     Endometrial  hyperplasia;;  Endometriosis;;   Menopausal  symptom   Bayer  Healthcare   Pharmaceuticals

1472. Mild Cognitive Impairment | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/mild-cognitive-impairment

1473. Stroke | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/stroke

1474. Hepatitis-C-Screening Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
      November 01, 2012 - injection drug users.16-22 About 60 percent of new infections occur in individuals who report injecting drugs … partners, unprotected sex, and/or sex with a person infected with HCV infection or using injection drugs … Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health

1475. Crosscutting-Horizon-Scan-High-Impact-1312 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
      December 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … It differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.

1476. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
      March 01, 2017 - If inflammation is part of the disease process, anti-inflammatory drugs may be effective. … Nonsteroidal Anti- Inflammatory Drugs (NSAIDs) • No evidence was available for the effect of low-dose … Antidementia Treatments • Low-strength evidence shows AChEI antidementia drugs did not reduce the incidence … instrumental activities of daily living; MCI=mild cognitive impairment; NSAIDs=nonsteroidal anti-inflammatory drugs

1477. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
      March 01, 2017 - If inflammation is part of the disease process, anti-inflammatory drugs may be effective. … Nonsteroidal Anti- Inflammatory Drugs (NSAIDs) • No evidence was available for the effect of low-dose … Antidementia Treatments • Low-strength evidence shows AChEI antidementia drugs did not reduce the incidence … instrumental activities of daily living; MCI=mild cognitive impairment; NSAIDs=nonsteroidal anti-inflammatory drugs

1478. Disposition of Comments for Diagnostic Accuracy of Screening and Treatment of Post-Acute Coronary Syndrome Depression (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-200-comments-post-acs.pdf
      November 14, 2017 - It is important that this list should not be interpreted as an endorsement of any of these drugs so … this point should be made the first time these drugs are mentioned. … The authors make it clear later in this report that the safety of the majority of these drugs has not … In both COPES and CODIACS, the study psychiatrist prescribed the drugs if the patient preferred an

1479. Pharmacologic and Non-pharmacologic Therapies in Adult Patients with Acute Exacerbation of COPD: A Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
      April 11, 2018 - considerations for AECOPD include short- acting/long-acting inhaled bronchodilators, anti-inflammatory drugs … in patients with advanced COPD suffering from an episode of AECOPD is unclear, especially as these drugs … mechanical ventilations • Complementary and alternative medicine interventions • Investigational drugs … and drugs that are only available outside of the U.S

1480. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
      September 01, 2011 - $3,355 per employee during a 3-year observation period—approximately 65 percent related to prescription drugs … .1 At the same time, it is well recognized that some drugs used to treat GERD (such as proton pump inhibitors … Among them are the publication of approximately 3,000 new studies; the introduction of novel drugs; the … The large disease burden, economic impact, and market potential for new drugs and devices explain the